There is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
| Orders | Qty | Bid |
|---|---|---|
| 1 | 242 | 1246.6 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| Ask | Qty | Orders |
|---|---|---|
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
Annual Revenue,rose 30.45%, in the last year to ₹5,135.28 Cr. Its sector's average revenue growth for the last fiscal year was 16.32%.Annual Net Profit,rose 142.45% in the last year to ₹94.82 Cr. Its sector's average net profit growth for the last fiscal year was 90.21%.Price to Earning Ratio,is 48.22, lower than its sector PE ratio of 53.52.Entero Healthcare Solutions Limited, incorporated in 2018, is one of India’s fastest-growing and trusted healthcare distribution platforms. The Company operates as a critical link between pharmaceutical manufacturers, hospitals, retail chemists, and patients, ensuring seamless access to healthcare products nationwide. Over a short span, Entero has established a strong infrastructure footprint, now spanning 500 districts across 20 states and 44 cities. Its network comprises 101 warehouses with 5.74 lakh sq. ft. of space, serving more than 95,300 retail pharmacies and 3,600 hospitals.
Entero’s product portfolio has grown to 80,600+ SKUs, sourced from 2,700+ manufacturers, including pharmaceutical companies, medical device makers, and healthcare consumables producers. The Company’s integrated distribution model not only ensures last-mile delivery but also supports demand generation, enabling manufacturers to expand their market access strategically.
Since inception, Entero has built scale both organically and inorganically, successfully executing multiple acquisitions across regions and segments. As of March 31, 2025, it had 47 subsidiaries, many acquired during FY2024–25 to strengthen geographic coverage and product categories.
The Company operates in a single reportable business segment: wholesale distribution of pharmaceutical goods.
Entero Healthcare Solutions Limited Key Management
Recognition: Awarded “Excellence in Health Supply Chain & Logistics – 2024” for its innovation and scale in pharmaceutical distribution.
Entero Healthcare operates as a wholesale distributor of pharmaceutical goods, medical devices, and healthcare consumables, connecting manufacturers to hospitals and pharmacies across India.
As of March 31, 2025, Entero had operations in 500 districts, 44 cities, and 20 states, with 101 warehouses, serving over 95,300 chemists and 3,600 hospitals.
The Company completed 10 acquisitions, launched the HealthEdge digital programme, crossed ₹5,000 crore in revenue, and achieved PAT above ₹100 crore for the first time.
